MedTrace Logo

Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy

NCT02425202 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-10-15

No results posted yet for this study

Summary

The study will evaluate the post-operative morphine-sparing effect, pain reduction, and side effects of a continuous ketamine infusion after tonsillectomy in pediatric patients.

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

DRUG

Ketamine

Post-operative continuous infusion until 0600 the next day

OTHER

Saline infusion

Post-operative continuous infusion until 0600 the next day

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Harley Wong, MD, FRCPC · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2018-05-03
Completion
2018-05-03

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02425202 on ClinicalTrials.gov